https://www.globenewswire.com/fr/news-release/2025/12/01/3197031/0/en/Propanc-Biopharma-Requests-Foreign-Filing-License-from-Spain-for-Methods-of-Treating-Resistant-Cancer-and-Fibrosis.html
Propanc Biopharma Requests Foreign Filing License from
These patents represent a significant turning point for Propanc and commercial potential of PRP for treating chronic diseases such as cancer and fibrosis...
foreign filingbiopharmarequestslicense
https://www.puertoricohealthcaredaily.com/article/845318759-propanc-biopharma-announces-plan-to-acquire-100-million-of-ethereum
Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum | Puerto Rico Healthcare Daily
https://uk.marketscreener.com/news/propanc-biopharma-inc-files-to-offer-resale-of-up-to-15-million-shares-of-common-stock-by-selling-ce7e50d9da8ef224
Propanc Biopharma Inc - files to offer resale of up to 15 million shares of common stock by selling...
Apr 10, 2026 - Propanc Biopharma Inc: Propanc Biopharma Inc - files to offer resale of up to 15 million shares of common stock by selling stockholder - SEC filing ...
https://www.propanc.com/news-media/press-releases/detail/156/propanc-biopharma-targets-site-of-first-in-human-study-for
Propanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter Mac Cancer Center,...